216 related articles for article (PubMed ID: 14756461)
1. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
[TBL] [Abstract][Full Text] [Related]
2. A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol.
Klimek L; Uhlig J; Mösges R; Rettig K; Pfaar O
Allergy; 2014 Dec; 69(12):1629-38. PubMed ID: 25130503
[TBL] [Abstract][Full Text] [Related]
3. Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double-blind placebo-controlled clinical trial.
Ahlbeck L; Ahlberg E; Stuivers L; Björkander J; Nyström U; Retsas P; Govindaraj D; Jenmalm MC; Duchén K
Clin Exp Allergy; 2023 Aug; 53(8):809-820. PubMed ID: 37013723
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract.
Bousquet J; Hejjaoui A; Skassa-Brociek W; Guérin B; Maasch HJ; Dhivert H; Michel FB
J Allergy Clin Immunol; 1987 Oct; 80(4):591-8. PubMed ID: 3668124
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis.
Devillier P; Dreyfus JF; Demoly P; Calderón MA
BMC Med; 2014 May; 12():71. PubMed ID: 24885894
[TBL] [Abstract][Full Text] [Related]
6. Critical appraisal of Timothy grass pollen extract GRAZAX in the management of allergic rhinitis.
Scaparrotta A; Attanasi M; Petrosino MI; Di Filippo P; Di Pillo S; Chiarelli F
Drug Des Devel Ther; 2015; 9():5897-909. PubMed ID: 26604688
[TBL] [Abstract][Full Text] [Related]
7. Development of a sublingual allergy vaccine for grass pollinosis.
Frati F; Scurati S; Puccinelli P; David M; Hilaire C; Capecce M; Marcucci F; Incorvaia C
Drug Des Devel Ther; 2010 Jul; 4():99-105. PubMed ID: 20689696
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.
Varney VA; Gaga M; Frew AJ; Aber VR; Kay AB; Durham SR
BMJ; 1991 Feb; 302(6771):265-9. PubMed ID: 1998791
[TBL] [Abstract][Full Text] [Related]
9. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts.
Bousquet J; Becker WM; Hejjaoui A; Chanal I; Lebel B; Dhivert H; Michel FB
J Allergy Clin Immunol; 1991 Jul; 88(1):43-53. PubMed ID: 2071784
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.
Bousquet J; Maasch H; Martinot B; Hejjaoui A; Wahl R; Michel FB
J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):439-46. PubMed ID: 3170992
[TBL] [Abstract][Full Text] [Related]
11. Immunological studies in vitro and in vivo of children with pollenosis given immunotherapy with an aqueous and a glutaraldehyde-treated tyrosine-absorbed grass pollen extract.
Foucard T; Johansson SG
Clin Allergy; 1976 Sep; 6(5):429-39. PubMed ID: 61825
[TBL] [Abstract][Full Text] [Related]
12. Use of glutaraldehyde-modified timothy grass pollen extract in nasal hyposensitisation treatment of hay fever.
Johansson SG; Deuschl H; Zetterström O
Int Arch Allergy Appl Immunol; 1979; 60(4):447-60. PubMed ID: 115801
[TBL] [Abstract][Full Text] [Related]
13. High dose grass pollen tablets used for hyposensitization in hay fever patients. A one-year double blind placebo-controlled study.
Mosbech H; Dreborg S; Madsen F; Ohlsson H; Stahl Skov P; Taudorf E; Weeke B
Allergy; 1987 Aug; 42(6):451-5. PubMed ID: 3310717
[TBL] [Abstract][Full Text] [Related]
14. Enzyme potentiated desensitisation in treatment of seasonal allergic rhinitis: double blind randomised controlled study.
Radcliffe MJ; Lewith GT; Turner RG; Prescott P; Church MK; Holgate ST
BMJ; 2003 Aug; 327(7409):251-4. PubMed ID: 12896934
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of grass-maize pollen oral immunotherapy in patients with seasonal hay-fever: a double-blind study.
Van Niekerk CH; De Wet JI
Clin Allergy; 1987 Nov; 17(6):507-13. PubMed ID: 3436031
[TBL] [Abstract][Full Text] [Related]
16. Lack of allergy to timothy grass pollen is not a passive phenomenon but associated with the allergen-specific modulation of immune reactivity.
Hinz D; Seumois G; Gholami AM; Greenbaum JA; Lane J; White B; Broide DH; Schulten V; Sidney J; Bakhru P; Oseroff C; Wambre E; James EA; Kwok WW; Peters B; Vijayanand P; Sette A
Clin Exp Allergy; 2016 May; 46(5):705-19. PubMed ID: 26662458
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of hayfever and pollen asthma in children with a new, modified allergen extract].
Zimmermann T; Beinder K; Mollet FE; Kroon AM
Immun Infekt; 1990 Aug; 18(4):127-31. PubMed ID: 2210795
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of immunotherapy with accelerated dosage schedules of polymerized grass and ragweed in patients with dual inhalant sensitivity.
Grammer LC; Shaughnessy MA; Shaughnessy JJ; Patterson R
J Allergy Clin Immunol; 1989 Apr; 83(4):750-6. PubMed ID: 2708735
[TBL] [Abstract][Full Text] [Related]
19. Specific IgE and IgG antibody responses in children to timothy pollen components during immunotherapy.
Nordvall SL; Renck B; Einarsson R
Allergy; 1989 Aug; 44(6):380-4. PubMed ID: 2802111
[TBL] [Abstract][Full Text] [Related]
20. Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis.
Mosbech H; Osterballe O
Allergy; 1988 Oct; 43(7):523-9. PubMed ID: 3148282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
